Search Results - Toor, Dr. Amir A.

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Increased Donor Inhibitory KIR Improve Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia: Subgroup Analysis

    Increased Donor Inhibitory KIR Improve Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia: Subgroup Analysis by Krieger, Elizabeth, Qayyum, Rehan, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    8 - Increased Donor Inhibitory KIR Improve Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia: Subgroup Analysis

    8 - Increased Donor Inhibitory KIR Improve Survival Following HLA Matched Unrelated Donor HCT in Pediatric Acute Leukemia: Subgroup Analysis by Krieger, Elizabeth, Qayyum, Rehan, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Utilizing Biomarkers, CRP and Ferritin, to Predict the Development of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor Cell Therapy

    Utilizing Biomarkers, CRP and Ferritin, to Predict the Development of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor Cell Therapy by Gor, Juhi, Abdelrahman, Mohamed, Shah, Vaani, Roberts, Catherine H., Krieger, Elizabeth, Simmons, Gary Lee, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    258 - Utilizing Biomarkers, CRP and Ferritin, to Predict the Development of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor Cell Therapy

    258 - Utilizing Biomarkers, CRP and Ferritin, to Predict the Development of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor Cell Therapy by Gor, Juhi, Abdelrahman, Mohamed, Shah, Vaani, Roberts, Catherine H., Krieger, Elizabeth, Simmons, Gary Lee, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    413 - To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations

    413 - To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations by Krieger, Elizabeth, Martin, Rebecca, Kmieciak, Maciej, Khorasanchi, Adam, Ansari, Amir, Farnsworth, Julie, Azouz, Louiza, Serrano, Myrna G, Buck, Gregory A, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations

    To CD16 or Not to CD16: Phenotypic Analysis of NK Cell Reconstitution after Myeloablative HLA Matched Unrelated HCT By CD16 Subpopulations by Krieger, Elizabeth, Martin, Rebecca, Kmieciak, Maciej, Khorasanchi, Adam, Ansari, Amir, Farnsworth, Julie, Azouz, Louiza, Serrano, Myrna G, Buck, Gregory A, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Allogeneic Hematopoietic Cell Transplants As Dynamical Systems: Effect of Early-Term Immune Suppression Intensity on Long-Term T Cell Recovery

    Allogeneic Hematopoietic Cell Transplants As Dynamical Systems: Effect of Early-Term Immune Suppression Intensity on Long-Term T Cell Recovery by Zelikson, Viktoriya, Sabo, Roy, Serrano, Myrna G, Aqeel, Younus, Ward, Savannah, Juhaishi, Taha Al, Krieger, Elizabeth, Simmons, Gary Lee, Roberts, Catherine H., Reed, Jason C, Buck, Gregory A, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    407 - Allogeneic Hematopoietic Cell Transplants As Dynamical Systems: Effect of Early-Term Immune Suppression Intensity on Long-Term T Cell Recovery

    407 - Allogeneic Hematopoietic Cell Transplants As Dynamical Systems: Effect of Early-Term Immune Suppression Intensity on Long-Term T Cell Recovery by Zelikson, Viktoriya, Sabo, Roy, Serrano, Myrna G, Aqeel, Younus, Ward, Savannah, Juhaishi, Taha Al, Krieger, Elizabeth, Simmons, Gary Lee, Roberts, Catherine H., Reed, Jason C, Buck, Gregory A, Toor, Dr. Amir A.

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

    Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study by Hill, Joshua A., Martens, Michael J., Young, Jo-Anne H., Bhavsar, Kavita, Kou, Jianqun, Chen, Min, Lee, Lik Wee, Baluch, Aliyah, Dhodapkar, Madhav Vishnu, Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Armistead, Paul M., Westervelt, Peter, McCarty, John M., McGuirk, Joseph P, Hamadani, Mehdi, DeWolf, Susan, Hosszu, Kinga, Sharon, Elad, Spahn, Ashley, Toor, Dr. Amir A., Waldvogel, Stephanie, Greenberger, Lee M., Auletta, Dr. Jeffery J., Horowitz, Mary M., Riches, Marcie L., Perales, Miguel-Angel

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: